Clinical Trials on Relapsed or Refractory Multiple Myeloma in Japan
Total 255 results
-
AmgenActive, not recruitingRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid LeukemiaUnited States, Australia, Japan, Germany, Canada
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
PfizerActive, not recruitingRelapsed or Refractory Multiple MyelomaJapan
-
TakedaCompletedRelapsed/Refractory Multiple MyelomaJapan
-
TakedaCompletedRelapsed and/or Refractory Multiple MyelomaJapan
-
TakedaCompleted
-
AmgenTerminatedRelapsed and/or Refractory Multiple MyelomaUnited States, Japan, Belgium, Australia, Switzerland
-
AbbVieActive, not recruiting
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaGermany, Korea, Republic of, Italy, France, Japan, Israel, Belgium, Denmark, Sweden, China, Spain, Czechia, Poland, Australia, Netherlands, Argentina, Canada, United Kingdom, Greece, Brazil, India
-
SymBio PharmaceuticalsCompletedRelapsed/Refractory Multiple MyelomaJapan
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaFrance, Czechia, Sweden, United States, Greece, Spain, Finland, Romania, Germany, Japan, Netherlands, Turkey, Austria, Bulgaria, Lithuania, Russian Federation, Slovakia
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Canada, Australia, China, Germany, Belgium, Malaysia, Turkey, Japan, Israel, Sweden, Spain, United Kingdom, Czechia, Denmark, Brazil, Italy, France, Netherlands, Poland, Austria, Portugal, Greece, India
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Italy, Korea, Republic of, Taiwan, China, Germany, Turkey, Japan, France, United Kingdom, Brazil, Spain, Czechia, Poland, Israel, Belgium, Greece, Netherlands
-
AmgenCompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaCanada, Belgium, Spain, United States, Korea, Republic of, Australia, Czechia, Taiwan, Hungary, Austria, Romania, Japan, United Kingdom, Greece, Turkey, Bulgaria, France, Russian Federation, Poland
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Austria, Denmark, Canada, Australia, China, Spain, Germany, United Kingdom, Hungary, Taiwan, Israel, Japan, India, Norway, Brazil, Italy, Greece, Korea, Republic of, Colombia, Singapore, Netherlands, Argentina, Hong Kong, Romani... and more
-
SanofiRecruitingRelapsed/Refractory Multiple MyelomaCzechia, Japan, Australia, Brazil, Greece, Portugal
-
CelgeneRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Australia, Italy, China, Spain, Germany, Romania, Korea, Republic of, Japan, United Kingdom, Czechia, Finland, France, Greece, Argentina, Belgium, Austria, Portugal, Israel, Poland, Brazil, Turkey, Canada, Ireland, New Zealand and more
-
Novartis PharmaceuticalsCompletedRelapse/Refractory Multiple MyelomaJapan
-
AmgenTerminatedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Japan, Germany, Netherlands, Canada
-
TeneoOne Inc.RecruitingRelapsed/Refractory Multiple MyelomaAustralia, Germany, Japan, Spain, United States, Italy, Poland
-
National University Hospital, SingaporeCelgene; International Myeloma FoundationUnknownRelapse Multiple MyelomaSingapore, Hong Kong, Japan, Korea, Republic of, Taiwan
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Brazil, Canada, France, Germany, Hungary, Ireland, Italy, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Ukraine, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | Non-Hodgkin Lymphoma (NHL)Belgium, Italy, Korea, Republic of, Hong Kong, Israel, Finland, Spain, Japan, United States
-
AmgenTerminatedRelapsed/Refractory Acute Myeloid Leukemia (AML)United States, Korea, Republic of, Australia, Japan, Germany, Canada
-
OncoTherapy Science, Inc.TerminatedRelapsed or Refractory Synovial SarcomaJapan
-
Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid Leukemia | Multiple Myeloma | Non-Hodgkin Lymphoma | Chronic Myeloid Leukemia | Acute Lymphoid LeukemiaJapan
-
TakedaCompletedRelapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell LymphomaJapan
-
Otsuka Pharmaceutical Co., Ltd.RecruitingMultiple Myeloma (MM)Japan
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid LeukemiaJapan
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Acute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | Non-Hodgkin Lymphoma (NHL)Japan
-
Jichi Medical UniversityTakara Bio Inc.UnknownRelapsed or Refractory B-Cell Non-Hodgkin LymphomaJapan
-
Otsuka Pharmaceutical Co., Ltd.Active, not recruitingRelapsed or Refractory Diffuse Large B-cell LymphomaJapan
-
Eisai Co., Ltd.CompletedRelapsed or Refractory B-cell Non-Hodgkin's LymphomaJapan
-
Mundipharma K.K.CompletedRecurrent or Refractory T/NK-cell MalignanciesJapan
-
Celgene CorporationTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Non-Hodgkin LymphomaJapan
-
TakedaCompleted
-
Janssen Pharmaceutical K.K.CompletedMultiple MyelomaJapan
-
Janssen Pharmaceutical K.K.Completed
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Mantle Cell Lymphoma | Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaJapan
-
CelgeneCompleted
-
Bristol-Myers SquibbCompleted
-
Novartis PharmaceuticalsActive, not recruitingMultiple Myeloma (MM)United States, Italy, Israel, Germany, Japan, Spain, Australia, Norway
-
GlaxoSmithKlineActive, not recruiting
-
Eli Lilly and CompanyCompleted
-
SymBio PharmaceuticalsTerminated
-
Kyowa Kirin Co., Ltd.CompletedMultiple Myeloma and Malignant LymphomaJapan
-
Daiichi Sankyo Co., Ltd.CompletedAcute Myeloid LeukemiaJapan
-
Janssen Pharmaceutical K.K.Completed